The US Food and Drug Administration (FDA) has granted orphan drug designation (ODD) and rare paediatric disease designation ...

Some of the market’s biggest winners start off as the smallest players. While trillion-dollar tech giants like the ...

Harbour BioMed (HKEX: 02142, the "Company"), a global biopharmaceutical company committed to the discovery, development and commercialization of novel antibody therapeutics focusing on immune-oncology ...

More than 10 million babies have been born through IVF, yet the process is still invasive and costly. Plus, why a venture ...

IPH4502 is a novel and differentiated topoisomerase I inhibitor ADC designed to precisely target Nectin-4, a cell adhesion molecule that is overexpressed in several types of solid tumors, including ...

"We appreciated the FDA reviewers' alignment with our proposed clinical development program, and their positive feedback on our intended clinical trial design, IND-enabling studies, and drug ...

The proposed guidance aims to provide a framework for the approval of personalised mRNA-based cancer vaccines.

A high speed pursuit in Tippecanoe county on January 31st ended with the arrest of 26-year-old Darryl Caldwell, who now faces multiple charges.

RNAi medicines, announced today that it will present new preclinical data demonstrating efficacy and safety of ETX-148 in murine models of haemophilia A and B at the Annual Congress of ...